The wire › SEC Form 8-K
Milestone Pharmaceuticals Inc. MIST
Filed with the SEC on Oct 28, 2026. Reported event date Oct 23, 2026.
- Business address
- Montreal, A8
- State
- Outside the U.S. or not given
- Incorporated in
- Outside the U.S. or not given
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1408443
- Accession number
- 0001104659-26-119669
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing